Equities

Ste Promotion Pharmaceutique du Maghreb SA

PRO:CAS

Ste Promotion Pharmaceutique du Maghreb SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (MAD)985.70
  • Today's Change0.00 / 0.00%
  • Shares traded55.00
  • 1 Year change--
  • Beta0.1442
Data delayed at least 20 minutes, as of May 02 2024 14:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ste Promotion Pharmaceutique du Maghreb SA, formerly known as Promopharm SA, is a Morocco-based company engaged in the pharmaceutical sector. It specializes in the production, marketing, import and export of pharmaceuticals, Para pharmaceuticals, dermo pharmaceuticals and cosmetics. In addition, the Company is involved in various types of industrial, commercial, financial, real estate and other operations related to its business. It also ensures the production and distribution of high-end dermo cosmetic products and manufactures, as a subcontractor, medicines on behalf of national and international laboratories.

  • Revenue in MAD (TTM)747.84m
  • Net income in MAD65.72m
  • Incorporated1947
  • Employees--
  • Location
    Ste Promotion Pharmaceutique du Maghreb SARue 7. zone industrielle du SahelBp 96/97, BerrechidHAD SOUALEM 26400MoroccoMAR
  • Phone+212 522964567
  • Fax+212 522964701
  • Websitehttp://www.promopharm.co.ma
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ste Promotion Pharmaceutique du Mghrb SA747.84m65.72m985.70m--15.002.189.681.3265.7265.72747.84452.610.95051.684.48--8.3510.7913.3215.9850.4052.278.7910.270.99818.470.187637.2411.766.639.152.7364.23--
Data as of May 02 2024. Currency figures normalised to Ste Promotion Pharmaceutique du Maghreb SA's reporting currency: Moroccan Dirham MAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.